Wednesday, July 27, 2016

UPDATE 2-GlaxoSmithKline invests $360 mln in UK despite Brexit vote

* Investment at sites making respiratory and biotech drugs

(Adds government reaction, more on other post-Brexit

investments)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)